<DOC>
	<DOCNO>NCT00264680</DOCNO>
	<brief_summary>Validation qolie-10 , epilepsy specific quality life questionnaire patient treat lamotrigine valproic acid . Comparison quality life epileptic patient treat lamotrigine valproic acid . Determination assessment comparative safety lamotrigine valproic acid . Assessment comparison body image perception woman treat lamotrigine valproic acid .</brief_summary>
	<brief_title>Spanish Validation Of Quality Life Questionnaire ( QOLIE-10 ) For Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Inclusion criterion : Diagnosis epilepsy normal neurological examination . Patients receive lamotrigine valproic acid stable dos monotherapy initiate 2 4 month . Exclusion criterion : Pregnant lactate woman . Previous treatment lamotrigine valproic acid . Secondary epilepsy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Validation questionnaire</keyword>
	<keyword>qolie-10</keyword>
	<keyword>epilepsy</keyword>
	<keyword>lamotrigine</keyword>
	<keyword>quality life</keyword>
</DOC>